OR-AIRSHIP
As organizations rush to adopt AI, a data-driven focus is foundational — not only to fuel better AI, but to avoid sacrificing long-term customer value for short-term gains. Nowhere is this more important than in mobile app experience, where value creation opportunities are 3-4X greater than anywhere else.
Today, mobile app experience company Airship introduced a host of enhancements to make continuous experimentation and optimization even easier.
From optimizing the performance of cross-channel customer journeys to refining messages, campaigns and no-code native app experiences, to testing app user experience and features themselves, all Airship experiments are now centralized in an Experimentation Hub. It’s a dashboard that anyone can use to create, launch and evaluate experiments and obtain a common understanding of the end-to-end experimentation and optimization strategy.
Holdout Experiments take A/B testing and control groups to a new level, allowing marketers to measure their impact on business goals by comparing audiences that receive marketing-led experiences versus those that don’t. Feature Flags enable teams to turn functionality on and off, run tests with control groups, activate short-term campaigns and make iterative experience enhancements before rolling them out to full audiences — all without the need for new code deployment or app store updates.
Airship has also centralized its visual reporting environment, providing real-time insights from all active experiments, as well as customer, channel and campaign data, into one place. A new App Health Reporting dashboard provides at-a-glance KPIs to help marketers and product owners understand app performance across the mobile app lifecycle.
Register to join two leading brand experts as they explore how continuous experimentation and optimization drives better results for businesses in a December 5 webinar.
Since the introduction of Airship’s no-code native App Experience Editor, businesses around the world have enabled non-technical teams to easily create, automate and adapt native app experiences for continuous onboarding and first-party and zero-party data collection. Numerous nominations for Airship’s annual customer awards program — The Altitude Awards — have documented their successes with agile creation and experimentation, including:
“Experimentation is fully integrated into Burger King France’s strategy, as we strive to deliver personalized, innovative experiences across all channels, from campaigns to product testing and new services,” said Valentin Pereira, CRM Project Manager. “Airship’s no-code native app experiences make it easy to go beyond messaging to optimize critical multiscreen app flows as well as important customer journeys and multi-channel campaigns. Results of initial app experience tests will have us repeating Airship Stories and videos at key moments in the customer journey — from welcoming new app users to launching major sales promotions.”
“Olio is fighting climate change by connecting people everywhere to give away rather than throw away, and share rather than shop, which makes our mobile app and notification opt-ins critical to facilitating rapid sharing and exchanges,” said Gareth Main, Chief Customer Officer at Olio. “Airship’s no-code native app experiences have enabled our entire team to quickly take action and experiment to improve users’ experiences, including recent tests that grew our notification opt-in rate by 24% while identifying a new approach we’ll take for future campaigns.”
“With more than 10 apps in total, we measure customer satisfaction daily. Previously, we used an HTML webview to deliver surveys to app users, which proved to be a distracting experience, resulting in low response rates,” said Laurent Claramonte, head of data analytics for Products and Mobile Apps, Orange France. “Since moving to Airship’s no-code native app experiences to quickly deploy, test and adapt onboarding flows, surveys and more, we now get as many customer survey responses in a day as we used to receive in a month.”
Winners of Airship’s Altitude Awards will be announced at Mobile Leaders Forum London later today.
“Customers’ first experiences with brands have an outsized impact on future value, especially when it comes to mobile app experiences where more than half decide whether to delete a new app in the first two uses,” said Brett Caine, CEO and president, Airship. “Brands need to recognize the limited window they have to make a compelling case for app customers to stick around. With Airship’s solution approach we are streamlining creation, experimentation and optimization, giving brands the keys to unlock agile optimization and more quickly achieve their business goals.”
About Airship
No one knows more, does more, or cares more than Airship when it comes to helping brands master mobile app experience (MAX).
From the beginning of apps, Airship powered the first commercial messages and then expanded its data-led approach to all re-engagement channels (mobile wallet, SMS, email), app UX experimentation, no-code native app experience creation and App Store Optimization (ASO).
Having powered trillions of mobile app interactions for thousands of global brands, Airship’s technology and deep industry expertise have enabled apps to become the digital center of customer experience, brand loyalty and monetization.
With the Airship App Experience Platform and Gummicube’s ASO technology and expertise, brands now have a complete set of solutions to optimize the entire mobile app customer journey – from the point of discovery to loyalty – driving greater value for everyone involved.
For more information, visit www.airship.com, read our blog or follow us on X (formerly Twitter), LinkedIn and Facebook.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231116362912/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Rock-It Company Expands Fine Art Logistics Capabilities of DIETL Through Acquisition of Several Strategic Infrastructure Services5.1.2026 15:00:00 CET | Press release
The acquisition strengthens DIETL’s fine art logistics operations through expanded access to specialized storage, handling and customs services. The Rock-It Company announced today that DIETL has acquired multiple fine art logistics specialists, strengthening its infrastructure and expanding access to specialized services across key U.S. art markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105175923/en/ The Rock-It Company Expands Fine Art Logistics Capabilities of DIETL Through Acquisition of Several Strategic Infrastructure Services The acquired companies include Delaware Freeport, Delaware National Art Company, Techno Export, and Registrar Technologies. Together, these businesses add depth across fine art storage, handling, packing, crating, installation support, customs brokerage, and technology-enabled logistics services, complementing DIETL’s existing operations. Delaware Freeport, a provider of high-security
TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models5.1.2026 14:54:00 CET | Press release
Falcon H1R 7B Packs Advanced Reasoning into a Compact 7 Billion Parameter Model Optimized for Speed and Efficiency TII’s Latest AI Model Outperforms Larger Rivals from Microsoft, Alibaba, and NVIDIA on Key Benchmarks The Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), has announced the release of Falcon H1R 7B, a next-generation AI model that takes a significant step toward making advanced AI more accessible than ever, by delivering world-class reasoning performance in a compact, efficient, and openly available format. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105981339/en/ TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models (Graphic: AETOSWire) With just 7 billion parameters, Falcon H1R 7B challenges and, in many cases, outperforms larger open-source AI models from around the world, including models fr
Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform5.1.2026 14:00:00 CET | Press release
Fundamental Cure for Intractable and Incurable Diseases using ‘Biological Age Zero’ Cells Derived from Patient’s Own Cells via SCNT TechnologyWorld's First Therapy Platform Simultaneously Solving Immune Rejection and Inheritance of Cellular Aging—The Major Hurdles of Existing Stem Cell TherapiesDrastically Improving Treatment Accessibility through the New Paradigm, ‘Patient-Initiated Clinical Trial™’, which Overcomes Existing Clinical Limitations Clonell Therapeutics, Inc., a leading biotechnology company dedicated to curing intractable and incurable diseases, announced today the official launch of the world's first 'Patient-Specific Embryonic Stem Cell (Somatic Cell Nuclear Transfer-derived Embryonic Stem Cell, hereinafter SCNT-ESC)' therapy platform based on Somatic Cell Nuclear Transfer (SCNT) technology. Concurrently, the company has initiated its innovative 'Patient-Initiated Clinical Trial™' to apply this breakthrough technology directly to patients. This platform launch is evalu
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq5.1.2026 13:30:00 CET | Press release
Helus Pharma builds on the strong foundation originally created as Cybin Inc., reflecting the Company’s ongoing transformation to a commercial stage pharmaceutical company Helus Pharma commences trading on Nasdaq Global Market (“Nasdaq”) and on Cboe Canada under ticker symbol: HELP Helus Pharma continues to progress its portfolio of novel serotonergic agonists (“NSAs”), with the goal of developing treatments designed to redefine mental health care, including HLP004 for the treatment of generalized anxiety disorder, with Phase 2 topline data readout expected in Q1 2026 Preparations in progress for the commercialization of HLP003, Helus Pharma’s NSA in Phase 3 clinical development, which has been granted Breakthrough Therapy Designation by the FDA for the adjunctive treatment of major depressive disorder This news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to it short form base shelf prospectus dated Sep
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse Large B-Cell Lymphoma5.1.2026 13:30:00 CET | Press release
- Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP met its primary endpoint of progression-free survival (PFS) - Based on these results, Incyte plans to file a supplemental Biologics License Application (sBLA) for tafasitamab and lenalidomide in addition to R-CHOP in first-line diffuse large B-cell lymphoma (DLBCL) in the first half of 2026 Incyte (Nasdaq:INCY) today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, and lenalidomide in addition to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) compared to R-CHOP alone as a first-line treatment for adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL) with an International Prognostic Index (IPI) score of three to five (3-5) for patients >60 years o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
